Tag: Drug Discovery
Agilisium earns AWS Life Sciences Competency Status, joining elite group of...
Agilisium's innovative GenAI-powered solutions recognized for transforming pharmaceutical R&D and accelerating drug discovery
Enzene launches discovery services division at BIO 2024
CDMO provides end-to-end drug discovery, development and commercialization services with sites in both the USA and Asia
India Unlimited: ICPA event in San Diego on 2nd June to...
Happening on the sidelines of US BIO 2024, the event will see top experts sharing their perspective on how international stakeholders can benefit from outsourcing their requirements to India
Syngene International reports Q4 FY24 consolidated PAT at Rs. 188.6 Cr
The company has reported total income of Rs. 933 crores during the period ended March 31, 2024
Aurigene Pharmaceutical introduces Aurigene.AI, an AIML assisted drug discovery platform
AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo
Experts discuss India’s alarming antibiotic misuse at International Conference on AMR...
Through collaborative efforts and interdisciplinary approaches, the conference aimed to address the challenges posed by AMR while exploring opportunities for novel drug discovery and vaccine development
New Delhi based Molecule AI launches SaaS solution to aid drug...
One of the standout features is the access to a vast repository of curated building blocks, providing researchers with the ability to explore and design novel molecules with precision and speed
Sai Life Sciences selects Dassault Systèmes’ solutions to accelerate drug discovery
“ONE Lab” enables Sai Life Sciences to build a comprehensive digital platform for research and development, and chemistry, manufacturing and controls laboratories, addressing common project implementation challenges
CPHI annual report predicts AI to transform all processes in drug...
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Unleashing the Power of Big Data: High Content Screening in the...
The demand for high content screening is projected to surge with a projected CAGR of 5.8%